Definitive Contract 75N91019C00049
Award Date 9/16/19
Potential Completion Date 6/15/20
Potential Value $300K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92121, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
4
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed Similar Awards
- This is a $300,000 Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Qoolabs Inc., a small disadvantaged business located in Carlsbad, California. The contract is for research and development under the Small Business Innovation Research (SBIR) program, with a period of performance through September 2025. Qoolabs is developing medical technologies related to infectious diseases, immunology,...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute awarded a Small Business Innovation Research (SBIR) Program Phase I contract to Crosslife Technologies Inc., a for-profit small business, for $299,987.00. The contract is for the development of a point of care nucleic acids test for the detection of the liver flukes Opisthorchis viverrini and Clonorchis. This contract is a Definitive Contract with a Firm Fixed Price pricing type. The...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a Small Business Innovation Research (SBIR) Phase I contract to Qoolabs Inc., a self-certified small disadvantaged business, to conduct research on finding human carriers of taeniasis to prevent neurocysticercosis epilepsy. The $150,000 firm-fixed-price contract was awarded on September 17, 2018 with a completion date of September 16, 2019. Qoolabs Inc. has received over $4 million in prime federal...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The $299,997.00 contract was awarded to Kephera Diagnostics LLC, a for-profit limited liability company, to develop screening and point-of-care diagnostic assays for the liver fluke infections Opisthorchis viverrini and Clonorchis sinensis. This SBIR contract, which was set...
- This federal contract award is for SBIR Phase II research and development work by Qoolabs Inc., a self-certified small disadvantaged business. The $749,999 cost-plus-fixed-fee contract was awarded on September 5, 2017 by the Department of Health and Human Services Centers for Disease Control and Prevention. The work is being performed in Atlanta, Georgia and involves the development of medical technologies related to infectious diseases, immunology, and cancer detection. This includes research...
- This $300,000 firm fixed price contract was awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Qoolabs Inc. of San Diego, California. The contract is for the development of point-of-care hepatitis C virus core antigen detection and was awarded under the Small Business Innovation Research program's solicitation PHS-2021-1. This total small business set-aside opportunity sought proposals for innovative...
- This definitive contract from the Department of Health and Human Services' National Institutes of Health and National Institute of Allergy and Infectious Diseases (HHS-NIH-NIAID) is valued at $600,000 to Qoolabs Inc. for monoclonal antibodies research aligned with SBIR Topic 107. The solicitation sought Small Business Innovation Research (SBIR) proposals across technical topics within NIH Institutes and CDC Centers to develop medical technologies, diagnostics, vaccines, cell therapies and...
- This $600,000 firm fixed price definitive contract was awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to Qoolabs Inc. of Carlsbad, California under Solicitation Number NIH-CDC-SBIR-2023 in response to Topic 118. The contractor will conduct research and development over a two year period to produce reagents for immunologic analysis of non-mammalian and underrepresented mammalian disease models, in support of the NIH and CDC's missions. This...
- This is a $717,999.84 cost plus fixed fee contract awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Qoolabs Inc., a self-certified small disadvantaged, woman-owned business. The contract was awarded under the Small Business Innovation Research (SBIR) Phase II program, which provides funding to small businesses for the research and development of innovative technologies. Under this contract, Qoolabs Inc. will conduct research and development...
- This $400,000 Small Business Innovation Research (SBIR) Phase I contract was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Amplifidx Inc., a woman-owned small business. The contract supports the development of cancer prevention and diagnosis technologies for low-resource settings over a two-year period. This award aligns with NCI's mission to support innovative medical device research and development by small businesses. As a SBIR...